Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jan 9;105(1):97–104. doi: 10.1111/cas.12319

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2013 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is noncommercial and no modifications or adaptations are made.

PMC Copyright notice

Cumulative incidence of relapse (CIR) of patients with acute promylocytic leukemia (APL) according to CD56 expression. (a) CIR for all patients showed an inferior trend in the CD56⁺ APL group (39.1% vs 24.3% at 9 years, P = 0.08). (b) In patients whose white blood cell (WBC) count was ≥3.0 × 10⁹/L, CIR for the CD56⁺ group was significantly higher compared to that for the CD56⁻ APL group (53.8% vs 28.9%, P = 0.03).